Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Jurnal Mahasiswa Manajemen dan Akuntansi Anggaran: Jurnal Publikasi Ekonomi dan Akuntansi
Risawati Risawati
Unknown Affiliation
Humanities Decision Sciences, Operations Research & Management Economics, Econometrics & Finance

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Jurnal Mahasiswa Manajemen dan Akuntansi

 1 
Pengaruh Fraud Diamond terhadap Finansial Statement Fraud pada Perusahaan Farmasi di Bursa Efek Indonesia Tahun 2021-2023 Eliza Paskah Lestari Gunantoro; Risawati Risawati
Jurnal Mahasiswa Manajemen dan Akuntansi Vol. 4 No. 2 (2025): Oktober : JUMMA'45: Jurnal Mahasiswa Manajemen dan Akuntansi
Publisher : Fakultas Ekonomi Universitas 45 Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30640/jumma45.v4i2.5125

Abstract

This research investigates the influence of the fraud diamond on financial statement fraud in pharmaceutical firms listed on the Indonesia Stock Exchange for the period 2021-2023. A purposive sampling method was used, resulting in a selection of 12 companies. The study relies on secondary data, which was gathered through documentation from the official website www.idx.co.id. To analyze the data, the research employs descriptive statistical analysis, classical assumption tests, determination tests, t-tests, and multiple linear regression analysis using SPSS 27 software. The findings reveal that the Nature of Industry significantly affects financial statement fraud, while other factors, including Financial Targets, Changes in Auditors, and Switches in Direction, do not have a significant impact on financial statement fraud. These results suggest that industry characteristics play a crucial role in shaping the likelihood of financial statement manipulation. Pharmaceutical companies with specific industry dynamics may face different pressures, which can influence their financial reporting practices. On the other hand, financial targets, auditor changes, and management changes do not appear to have a substantial direct impact, indicating that other factors not covered in the study might be influencing financial fraud behaviors. This study provides valuable insights for regulators, auditors, and stakeholders in the pharmaceutical sector to better understand the risk factors associated with financial statement fraud.
Co-Authors Eliza Paskah Lestari Gunantoro